12th Dec 2007 09:01
Smith & Nephew Plc12 December 2007 FOR IMMEDIATE RELEASE Smith & Nephew launch new ALLEVYN* product range at European Customer Conference Product range increases capacity of healthcare professionals to minimise painand fight infection Hull, (U.K), December 12 2007 The Advanced Wound Management business unit of Smith & Nephew (LSE: SN; NYSE:SNN) launched its new ALLEVYN* product range at an exclusive conference inLondon this weekend, highlighting the benefits of the new range to over 250European healthcare professionals. Customers from across Europe were brought together to see the newly extended anddefined ALLEVYN product range, which continues to provide the 'best path tohealing' but also now addresses the issues of pain and infection. Following the successful launch of ALLEVYN Ag in October 2007, an additional twonew products have been added to the product range, ALLEVYN Gentle and ALLEVYNGentle Border. The ALLEVYN product range further expands the healthcareprofessionals' capacity to help fight infection, minimise pain, maximise patientcomfort and optimise healing for patients in more situations. Chaired by Professor Aidan Halligan, former Deputy Chief Medical Officer andDirector of Clinical Governance for the NHS and now Chief Executive Officer ofEllison Health Ltd, the conference covered everything from understanding some ofthe key issues in today's woundcare, such as quality of life and managinginfection to the science behind the ALLEVYN range and its relation to clinicalpractice, as well as a full introduction to the new products in the ALLEVYNrange. Attendees also heard from a range of clinical professionals from acrossEurope on their experiences of managing wounds and removing barriers to healingwith ALLEVYN. Professor Halligan commented on the conference, "This conference succeeded inreawakening the attending European Healthcare professional's collective passionfor patient care, a fundamental principle of overall successful wound care. Thediversity of the conference included everything from authentic patientperspectives of living with life threatening wounds, all the way to improvingquality of life in palliative care." Donna O'Shea from the Tissue Viability Team at Cornwall and Isle of ScillyPrimary Care Trust, said about the conference, "Inspirational values andpersonal experiences shared from and with many European colleagues made this anexciting and interesting launch of products delivered with realism and passion." Enquiries Sidonie Myers Tel: +44 (0) 1482 673246Head of CommunicationSmith & Nephew Advanced Wound Management Notes for Editors ALLEVYN now further simplifies customer choice, by providing a new, unique andpowerful combination of benefits through each of the four product groups in itsnewly defined and extended range. ALLEVYN has now combined the proven strengthsof its triple-action ALLEVYN technology with a new level of versatility andbreadth of application. The three new products in the range are: ALLEVYN Ag - All the benefits of ALLEVYN, with the addition of anti-microbialsilver for use on wounds with suspected infection or infected wounds treated asper local protocol. ALLEVYN Gentle Border - All the benefits of ALLEVYN with the addition of asilicone gel adhesive for use on patients with fragile skin where secondaryretention is not used. ALLEVYN Gentle - All the benefits of ALLEVYN with the addition of a soft geladhesive for use on patients with fragile skin when secondary retention isrequired About Smith & Nephew Smith & Nephew Advanced Wound Management is headquartered in the United Kingdom.The organisation has manufacturing centres in the United Kingdom and Largo, FL. Smith & Nephew is a global medical technology business, specialising inOrthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopyand Advanced Wound Management products. Smith & Nephew is a global leader inarthroscopy and advanced wound management and is one of the leading globalorthopaedics companies. Smith & Nephew is dedicated to helping improve people's lives. The Companyprides itself on the strength of its relationships with its surgeons andprofessional healthcare customers, with whom its name is synonymous with highstandards of performance, innovation and trust. The Company operates in 32countries around the world. Annual sales in 2006 were nearly $2.8 billion. Forward-Looking Statements This press release contains certain "forward-looking statements" within themeaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regardingexpected revenue growth and trading margins discussed under "Outlook" areforward-looking statements as are discussions of our product pipeline. Thesestatements, as well as the phrases "aim", "plan", "intend", "anticipate","well-placed", "believe", "estimate", "expect", "target", "consider" and similarexpressions, are generally intended to identify forward-looking statements. Suchforward-looking statements involve known and unknown risks, uncertainties andother important factors (including, but not limited to, the outcome oflitigation, claims and regulatory approvals) that could cause the actualresults, performance or achievements of Smith & Nephew, or industry results, todiffer materially from any future results, performance or achievements expressedor implied by such forward-looking statements. Please refer to the documentsthat Smith & Nephew has filed with the U.S. Securities and Exchange Commissionunder the U.S. Securities Exchange Act of 1934, as amended, including Smith &Nephew's most recent annual report on Form 20F, for a discussion of certain ofthese factors. All forward-looking statements in this press release are based on informationavailable to Smith & Nephew as of the date hereof. All written or oralforward-looking statements attributable to Smith & Nephew or any person actingon behalf of Smith & Nephew are expressly qualified in their entirety by theforegoing. Smith & Nephew does not undertake any obligation to update or reviseany forward-looking statement contained herein to reflect any change in Smith &Nephew's expectation with regard thereto or any change in events, conditions orcircumstances on which any such statement is based. * Trademark of Smith & Nephew. Certain marks registered US Patent and TrademarkOffice. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Smith & Nephew